Compound Profiles

CJC-1295: With and Without DAC - Research Comparison

CJC-1295: With and Without DAC - Research Comparison

CJC-1295 is a synthetic growth hormone-releasing hormone (GHRH) analog primarily used in research settings to study growth hormone (GH) secretion and its downstream effects. It exists in two main forms: CJC-1295 without Drug Affinity Complex (DAC), sometimes referred to as Mod GRF 1-29, and CJC-1295 with DAC. Understanding the differences between these two forms is crucial for researchers aiming to design and interpret their experiments effectively.

Molecular Structure and Mechanism of Action

Both CJC-1295 with and without DAC stimulate the release of GH from the pituitary gland by binding to the GHRH receptor. However, their pharmacokinetic profiles differ significantly due to the presence of the DAC moiety.

CJC-1295 Without DAC (Mod GRF 1-29)

Mod GRF 1-29 is a modified version of the endogenous GHRH(1-29)NH2 peptide. Its sequence is: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2. The modifications at positions 2 and 8 (D-Ala and Gln substituted for Ala and Asp, respectively) enhance its stability and resistance to enzymatic degradation compared to native GHRH. It has a short half-life, typically lasting only a few minutes.

Mechanism of Action: Mod GRF 1-29 binds to the GHRH receptor on somatotrophs in the anterior pituitary gland, activating the Gs signaling pathway. This leads to increased intracellular cAMP levels, ultimately triggering the release of GH. The pulsatile nature of GH secretion is maintained, as Mod GRF 1-29 only stimulates GH release when endogenous somatostatin levels are low.

CJC-1295 With DAC

CJC-1295 with DAC consists of the Mod GRF 1-29 peptide linked to a maleimide derivative of polyethylene glycol (PEG). This DAC moiety allows for covalent binding to albumin in the bloodstream. This binding significantly extends the half-life of the peptide, lasting for several days. The DAC moiety itself is typically a branched PEG molecule with a molecular weight ranging from 2 kDa to 30 kDa depending on the specific synthesis. The maleimide group reacts with free thiol groups on albumin, forming a stable thioether bond.

Mechanism of Action: Similar to Mod GRF 1-29, CJC-1295 with DAC binds to the GHRH receptor. However, due to its extended half-life, it provides a more sustained stimulation of GH release. The binding to albumin protects the peptide from rapid degradation and clearance, allowing for less frequent administration.

Research Applications

Both CJC-1295 variants have been employed in research studies investigating various aspects of GH secretion and its effects. The choice between the two depends on the specific research question and the desired pharmacokinetic profile.

CJC-1295 Without DAC (Mod GRF 1-29)

  • Pharmacokinetic studies: Used to investigate the short-term effects of GHRH stimulation and to model the pulsatile release of GH.
  • Combination therapies: Often used in combination with GH-releasing peptides (GHRPs) like Ipamorelin or GHRP-6 to achieve synergistic GH release. The short half-life of Mod GRF 1-29 allows for precise control over the duration of stimulation.
  • Dose-response studies: Suitable for determining the optimal dose of GHRH analog needed to elicit a specific GH response.

CJC-1295 With DAC

  • Long-term GH stimulation studies: Ideal for investigating the effects of sustained GH elevation on various physiological parameters, such as muscle growth, fat loss, and bone density.
  • Frequency of administration studies: Used to determine the optimal dosing interval for achieving consistent GH levels over extended periods.
  • Comparative studies: Can be compared to other GH-stimulating agents to assess their relative efficacy and safety profiles.

Quality Markers to Look For

Ensuring the quality of CJC-1295 peptides is paramount for obtaining reliable research results. Several quality markers should be considered when sourcing and evaluating these peptides.

Purity

Peptide purity refers to the percentage of the desired peptide sequence in the sample. High purity is essential to minimize the risk of confounding results due to the presence of unwanted peptides or synthesis byproducts. Purity is typically determined by analytical HPLC (High-Performance Liquid Chromatography) with UV detection at 214 nm or 220 nm. A purity level of ?98% is generally considered acceptable for research purposes. Mass spectrometry (MS) should also be used to confirm the identity of the peptide and to detect any major impurities.

Practical Tip: Request a Certificate of Analysis (CoA) from the supplier that includes HPLC and MS data. Carefully examine the chromatogram for any significant impurity peaks. A reputable supplier will provide detailed information about the analytical methods used and the acceptance criteria for purity.

Peptide Content

Peptide content refers to the actual amount of peptide present in the sample, taking into account factors such as water content and residual solvents. It is usually expressed as a percentage. A peptide that is 98% pure by HPLC may still have a peptide content lower than 98% due to the presence of water or counterions.

Practical Tip: Look for peptide content information on the CoA. Common methods for determining peptide content include quantitative amino acid analysis (AAA) and elemental analysis. AAA provides a direct measurement of the amino acid composition of the peptide, while elemental analysis can be used to determine the amount of nitrogen present, which can then be related to the peptide content.

Water Content

Peptides are hygroscopic and can absorb water from the environment. Excessive water content can affect the accuracy of dosing and can contribute to peptide degradation. Water content is typically determined by Karl Fischer titration. A water content of ?10% is generally considered acceptable.

Practical Tip: Request information about the water content of the peptide from the supplier. Store the peptide in a tightly sealed container with a desiccant to minimize water absorption.

Counterion Content

During peptide synthesis and purification, counterions (e.g., acetate, trifluoroacetate (TFA)) are often introduced to neutralize the charged amino acid residues. The presence of counterions can affect the weight and purity of the peptide. TFA is a common counterion used in peptide synthesis, but it can be difficult to remove completely and can potentially interfere with certain biological assays. Acetate is often preferred as a counterion because it is more easily removed and less likely to cause adverse effects.

Practical Tip: Inquire about the counterion used during peptide synthesis and purification. Request information about the counterion content. If TFA is present, consider using a peptide with an acetate counterion if possible, especially if the peptide will be used in cell-based assays or in vivo studies.

Amino Acid Analysis

Amino acid analysis (AAA) is a quantitative technique used to determine the amino acid composition of a peptide. It involves hydrolyzing the peptide into its constituent amino acids and then quantifying the amount of each amino acid present. AAA can be used to confirm the identity of the peptide and to detect any amino acid deletions or substitutions. Deviations from the expected amino acid ratios can indicate peptide degradation or incomplete synthesis.

Practical Tip: Request AAA data from the supplier, especially for complex or modified peptides. Compare the measured amino acid ratios to the theoretical ratios. Significant discrepancies may indicate a problem with the peptide.

Mass Spectrometry

Mass spectrometry (MS) is a powerful technique used to determine the molecular weight of a peptide. It can be used to confirm the identity of the peptide and to detect any modifications or truncations. Common MS techniques used for peptide analysis include electrospray ionization mass spectrometry (ESI-MS) and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS).

Practical Tip: Request MS data from the supplier. The measured molecular weight should match the theoretical molecular weight of the peptide within a certain tolerance (e.g., ±0.1%). The presence of multiple peaks or peaks with unexpected masses may indicate the presence of impurities or degradation products.

Common Impurities

Several types of impurities can be present in synthetic peptides. Identifying and minimizing these impurities is critical for obtaining reliable research results.

  • Truncated Sequences: Peptides missing one or more amino acids from either the N-terminus or C-terminus. These arise from incomplete coupling during solid-phase peptide synthesis.
  • Deletion Sequences: Peptides missing one or more amino acids from within the sequence. These can occur due to incomplete deprotection or side-chain reactions.
  • Modified Amino Acids: Peptides containing amino acids with incorrect protecting groups or side-chain modifications.
  • Diketopiperazines (DKPs): Cyclic dipeptides formed by intramolecular cyclization of the N-terminal dipeptide. DKPs are particularly common when proline is present at the second position.
  • Aggregation Products: Peptides that have aggregated to form dimers, trimers, or larger oligomers. Aggregation can be promoted by hydrophobic amino acids or by the presence of disulfide bonds.
  • Solvents and Reagents: Residual solvents (e.g., DMF, acetonitrile) and reagents (e.g., TFA, scavengers) used during peptide synthesis and purification.

Storage Requirements

Proper storage is essential to maintain the stability and integrity of CJC-1295 peptides. Follow these guidelines for optimal storage:

  • Lyophilized Form: Store lyophilized peptides at -20°C or -80°C in a tightly sealed container with a desiccant. Avoid repeated freeze-thaw cycles.
  • Solution Form: If the peptide is reconstituted in solution, store it at -20°C or -80°C in single-use aliquots. Avoid repeated freeze-thaw cycles. The choice of solvent can also affect peptide stability. Sterile water, PBS, or acetic acid solutions (e.g., 0.1% acetic acid) are commonly used. The optimal pH range for storage is typically between 5 and 7.
  • Light Sensitivity: Protect peptides from light by storing them in amber vials or wrapping them in aluminum foil.
  • Humidity: Store peptides in a low-humidity environment to minimize water absorption.
  • Expiration Date: Pay attention to the expiration date provided by the supplier. Peptides may degrade over time, even under optimal storage conditions.

Comparison Table: CJC-1295 With and Without DAC

Feature CJC-1295 Without DAC (Mod GRF 1-29) CJC-1295 With DAC
Half-life Minutes (typically ~30 minutes) Days (typically 6-8 days)
Mechanism of Action Binds directly to GHRH receptor, stimulating pulsatile GH release. Binds directly to GHRH receptor, stimulating sustained GH release due to prolonged half-life from albumin binding.
Frequency of Administration More frequent administrations required (e.g., multiple times per day). Less frequent administrations required (e.g., once or twice per week).
Suitable Research Applications Pharmacokinetic studies, combination therapies, dose-response studies. Long-term GH stimulation studies, frequency of administration studies, comparative studies.
Cost Generally less expensive per dose. Generally more expensive per dose.

Sourcing Considerations

Selecting a reputable supplier is crucial for obtaining high-quality CJC-1295 peptides. Consider the following factors when choosing a supplier:

  • Reputation: Choose a supplier with a proven track record of providing high-quality peptides. Look for reviews and testimonials from other researchers.
  • Quality Control: Ensure that the supplier has robust quality control procedures in place, including HPLC, MS, and AAA. Request a Certificate of Analysis (CoA) for each batch of peptide.
  • Peptide Synthesis Expertise: Select a supplier with expertise in peptide synthesis and purification. Inquire about the synthesis methods used and the purification techniques employed.
  • Customer Support: Choose a supplier that provides excellent customer support and is responsive to your questions and concerns.
  • Price: While price is an important consideration, it should not be the sole factor. Prioritize quality and reliability over price.

Practical Tip: Order a small quantity of peptide initially to evaluate its quality before placing a larger order. Perform your own independent analysis of the peptide to verify the supplier's CoA data.

Key Takeaways

  • CJC-1295 exists in two main forms: with and without DAC, each with distinct pharmacokinetic profiles.
  • Mod GRF 1-29 (without DAC) has a short half-life, resulting in pulsatile GH release.
  • CJC-1295 with DAC has an extended half-life, leading to sustained GH stimulation.
  • Purity, peptide content, water content, counterion content, AAA, and MS are critical quality markers.
  • Proper storage at -20°C or -80°C in a tightly sealed container with a desiccant is essential.
  • Choose a reputable supplier with robust quality control procedures and excellent customer support.
This guide is intended for research purposes. Consult relevant regulations before purchasing peptides.

Related Articles